Novo Nordisk Appeals to U.S. Third Circuit Court on Biden Administration's Medicare Drug Price Negotiation Program (MDPNP)。Previously, Johnson & Johnson, Bristol-Myers Squibb, and AstraZeneca all appealed to circuit court against the U.S. government's drug price negotiation program。
US Stock 7x24
2024-08-16 00:08:09
2.22W
Novo Nordisk Appeals to U.S. Third Circuit Court on Biden Administration's Medicare Drug Price Negotiation Program (MDPNP)。
Previously, Johnson & Johnson, Bristol-Myers Squibb, and AstraZeneca all appealed to circuit court against the U.S. government's drug price negotiation program。
Disclaimer: The views in this article are from the original author and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.